Clinical Trial Update: Adalimumab for Inflammatory Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on adalimumab for inflammatory osteoarthritis. This Phase 1/2 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: University of Alberta | Conditions: Osteoarthritis | Phase 1, Phase 2 | Status: COMPLETED